✦ LIBER ✦

Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease

✍ Scribed by J Waiser; K Budde; M Schreiber; K Korn; S Stenglein; J-T Drenckhahn; T Böhler; I Hauser; H.-H Neumayer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Active Cytomegalovirus Dise

✍ Stanley C. Jordan; Ashley Vo; Suphamai Bunnapradist; Mieko Toyoda; Elaine Kamil 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Prophylaxis of cytomegalovirus disease w

✍ A Sancho; J.L Górriz; J.F Crespo; A Avila; M.J Alcaraz; J.L Garcı́a Ramos; L.M P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Preemptive Therapy With Intravenous Ganc

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Deferred versus prophylactic therapy wit

✍ G Lianghui; Z Shusen; L Tingbo; S Yan; W Weilling; L Anwei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Prophylaxis of cytomegalovirus disease w

✍ E Morales; A Andrés; E González; J.C Herrero; M.A Muñoz; M Ortiz; B Espejo; C Lu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Successful use of oral ganciclovir for t

✍ D.P. Puliyanda; N.S. Silverman; D. Lehman; A. Vo; S. Bunnapradist; R.K. Radha; M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB